Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH

Clinical trial NCT02652429 · UNKNOWN

Trial details

NCT number: NCT02652429
Sponsor: Bellerophon Pulse Technologies
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2016-03-01
Primary completion: 2023-04-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.